People
are our inspiration
Home / People / NOMIS Awardee / Ronald M. Evans

Ronald M. Evans

Ronald M. Evans

Loading...

NOMIS Project(s)

Ronald M. Evans is a 2020 NOMIS Distinguished Scientist and has been a professor at the Salk Institute for Biological Studies since 1978, the director of Salk’s Gene Expression Laboratory since 1995 as well as holder of the March of Dimes Chair in Molecular and Developmental Biology since 1998. He is leading the project The Science of Health: The Fundamental Mechanisms of Organ Communication.

Evans grew up in Los Angeles, California (US) and earned a BA in bacteriology and PhD in microbiology and immunology from the University of California, Los Angeles. He completed his postdoctoral work at Rockefeller University (US) in 1978 before becoming a faculty member at Salk that same year. He has received numerous honors and awards, including the Wolf Prize in Medicine, the Albany Medical Center Prize in Medicine and Biomedical Research, the Canada Gairdner Foundation International Award, the Albert Lasker Award for Basic Medical Research, the March of Dimes Prize and the Keio Medical Science Prize. He was elected to the National Academy of Sciences in 1989 and the National Academy of Medicine in 2003.

Evans has made multiple significant contributions to science, including the discovery of a “superfamily” of molecules called nuclear hormone receptors (NRs), whose members respond to various steroid and thyroid hormones, vitamins A and D, as well as to dietary fats and bile acids. This led to the unifying theory that hormones control gene networks throughout the body, which in turn control physiologic pathways from embryonic development through adulthood. Evans has also identified multiple novel pathways involved in cancer and diabetes that are targetable by drugs that activate these receptors. More recently, he identified exercise mimetics (“exercise in a pill”), a class of drugs that stimulate gene networks in muscle tissue. By directly acting on genes, exercise mimetics confer the benefits of fitness without training — pointing to potential new therapies for children with muscular dystrophy, adults with type 2 diabetes and obese individuals. Evans is further investigating NRs to understand the mechanisms of cooperativity between interconnected networks including the brain, endocrine glands, gut, liver, immune cells and the microbiome.

Ronald M. Evans | Awards Film

Ronald M. Evans | Insights Film

Ronald M. Evans's News

NOMIS Awardee and Salk Professor Ronald Evans has been named the 2024 recipient of the Japan Prize in the field of Medical Science and Pharmaceutical Science The Japan Prize Foundation awards hellip

In an article published in Gastroenterology NOMIS Awardee Ronald M Evans and colleagues report that a protein known as estrogen related receptor gamma ERR ɣ is critical for preventing pancreatic auto digestion hellip

Recognizing their outstanding contributions to the advancement of science and human progress through their pioneering collaborative research the 2021 as well as the 2020 NOMIS Distinguished Scientist and Scholar Award hellip

Ronald M. Evans's Insights

Abstract: Colorectal cancer CRC is driven by genomic alterations in concert with dietary influences with the gut microbiome implicated as an effector in disease development and progression While meta analyses have provided mechanistic insight into patients with CRC study heterogeneity has limited causal associations Using multi omics studies on genetically controlled
Abstract: Molecular classification of gastric cancer GC identified a subgroup of patients showing chemoresistance and poor prognosis termed SEM Stem like Epithelial to mesenchymal transition Mesenchymal type in this study Here we show that SEM type GC exhibits a distinct metabolic profile characterized by high glutaminase GLS levels Unexpectedly SEM type